Semler Scientific, Inc. SMLR
We take great care to ensure that the data presented and summarized in this overview for Semler Scientific, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding SMLR
View all-
Interchange Capital Partners, LLC1.27MShares$29.1 Million7.54% of portfolio
-
Morgan Stanley New York, NY1.23MShares$28.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA701KShares$16.1 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il403KShares$9.25 Million0.0% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA396KShares$9.08 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA385KShares$8.83 Million0.0% of portfolio
-
Black Rock Inc. New York, NY349KShares$7.99 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA300KShares$6.89 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY277KShares$6.36 Million0.0% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL254KShares$5.82 Million0.0% of portfolio
Latest Institutional Activity in SMLR
Top Purchases
Top Sells
About SMLR
Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. Its products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups. The company offers its products through salespersons and distributors. Semler Scientific, Inc. was incorporated in 2007 and is headquartered in Santa Clara, California.
Insider Transactions at SMLR
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 17
2025
|
Douglas Murphy Chutorian CEO, interim CFO and Director |
BUY
Bona fide gift
|
Indirect |
54,594
+18.45%
|
-
|
|
Nov 17
2025
|
Douglas Murphy Chutorian CEO, interim CFO and Director |
SELL
Bona fide gift
|
Direct |
54,594
-100.0%
|
-
|
|
Nov 17
2025
|
Douglas Murphy Chutorian CEO, interim CFO and Director |
SELL
Open market or private sale
|
Direct |
70,406
-32.53%
|
$1,408,120
$20.41 P/Share
|
|
Nov 17
2025
|
Douglas Murphy Chutorian CEO, interim CFO and Director |
BUY
Exercise of conversion of derivative security
|
Direct |
125,000
+50.0%
|
$250,000
$2.23 P/Share
|
|
Aug 25
2025
|
Douglas Murphy Chutorian CEO, interim CFO and Director |
BUY
Bona fide gift
|
Indirect |
31,396
+14.39%
|
-
|
|
Aug 25
2025
|
Douglas Murphy Chutorian CEO, interim CFO and Director |
SELL
Bona fide gift
|
Direct |
31,396
-100.0%
|
-
|
|
Aug 25
2025
|
Douglas Murphy Chutorian CEO, interim CFO and Director |
SELL
Open market or private sale
|
Direct |
28,604
-47.67%
|
$858,120
$30.54 P/Share
|
|
Aug 25
2025
|
Douglas Murphy Chutorian CEO, interim CFO and Director |
BUY
Exercise of conversion of derivative security
|
Direct |
60,000
+50.0%
|
$120,000
$2.56 P/Share
|
|
Jun 11
2025
|
Renae Cormier Chief Financial Officer |
BUY
Bona fide gift
|
Indirect |
3,746
+50.0%
|
-
|
|
Jun 11
2025
|
Renae Cormier Chief Financial Officer |
SELL
Bona fide gift
|
Direct |
3,746
-100.0%
|
-
|
|
Jun 11
2025
|
Renae Cormier Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,746
+50.0%
|
$112,380
$30.48 P/Share
|
|
Jun 11
2025
|
Eric Semler Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,750
+1.05%
|
$155,250
$23.32 P/Share
|
|
Dec 16
2024
|
Eric Semler Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,875
+1.24%
|
$181,125
$23.32 P/Share
|
|
Dec 16
2024
|
William H Chang Director |
SELL
Bona fide gift
|
Indirect |
2,735
-0.62%
|
-
|
|
Dec 12
2024
|
Douglas Murphy Chutorian CEO, interim CFO and Director |
BUY
Bona fide gift
|
Indirect |
55,000
+26.15%
|
-
|
|
Dec 12
2024
|
Douglas Murphy Chutorian CEO, interim CFO and Director |
SELL
Bona fide gift
|
Direct |
55,000
-100.0%
|
-
|
|
Dec 11
2024
|
Douglas Murphy Chutorian CEO, interim CFO and Director |
SELL
Open market or private sale
|
Direct |
25,000
-4.48%
|
$1,525,000
$61.68 P/Share
|
|
Dec 11
2024
|
Douglas Murphy Chutorian CEO, interim CFO and Director |
BUY
Exercise of conversion of derivative security
|
Direct |
14,917
+15.72%
|
$44,751
$3.44 P/Share
|
|
Dec 10
2024
|
Douglas Murphy Chutorian CEO, interim CFO and Director |
SELL
Open market or private sale
|
Direct |
75,000
-16.42%
|
$4,500,000
$60.96 P/Share
|
|
Dec 10
2024
|
Douglas Murphy Chutorian CEO, interim CFO and Director |
BUY
Exercise of conversion of derivative security
|
Direct |
140,083
+50.0%
|
$420,249
$3.44 P/Share
|
Last 12 Months Summary
| Bona fide gift | 145K shares |
|---|---|
| Exercise of conversion of derivative security | 358K shares |
| Bona fide gift | 147K shares |
|---|---|
| Open market or private sale | 199K shares |